Q1 2025 · 13F-HR
Affinity Asset Advisors, LLCholdings as filed
Filed 2025-05-14 · accession 0001999371-25-006074
$1.05B
Reported value
98
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $223.8M | 21.4% | 400,000 | PUT | SOLE |
| 464287655 | IWM | ISHARES TR | $59.8M | 5.71% | 300,000 | PUT | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $44.6M | 4.25% | 1,328,175 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $43.0M | 4.10% | 1,151,199 | Common | SOLE |
| 78464A870 | XBI | SPDR SERIES TRUST | $40.5M | 3.87% | 500,000 | PUT | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $39.0M | 3.73% | 615,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $34.8M | 3.32% | 530,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $33.0M | 3.15% | 1,000,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $32.6M | 3.11% | 460,000 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $26.5M | 2.53% | 80,000 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $22.2M | 2.12% | 1,546,662 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $21.8M | 2.08% | 70,000 | CALL | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $21.5M | 2.05% | 1,400,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $19.3M | 1.85% | 400,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $19.2M | 1.83% | 1,070,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $17.5M | 1.67% | 1,100,000 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $16.8M | 1.60% | 30,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $14.9M | 1.42% | 55,000 | CALL | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $14.7M | 1.41% | 1,825,000 | Common | SOLE |
| 682143AG7 | OMER 5.25 02/15/26 | OMEROS CORP | $14.3M | 1.36% | 15,525,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $13.6M | 1.29% | 321,962 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $11.7M | 1.11% | 100,000 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $11.6M | 1.11% | 15,250,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $11.4M | 1.09% | 280,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $10.7M | 1.02% | 140,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $10.4M | 0.99% | 300,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $9.6M | 0.92% | 810,669 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $8.5M | 0.81% | 355,143 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $8.3M | 0.80% | 172,500 | CALL | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $8.0M | 0.76% | 70,000 | CALL | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $7.9M | 0.75% | 1,250,000 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $7.8M | 0.74% | 481,678 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $7.3M | 0.70% | 430,000 | Common | SOLE |
| 89422GAA5 | TVTX 2.25 03/01/29 | TRAVERE THERAPEUTICS INC | $7.0M | 0.67% | 7,000,000 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $6.7M | 0.63% | 325,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $6.4M | 0.61% | 265,000 | CALL | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $5.6M | 0.53% | 545,362 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $5.5M | 0.53% | 50,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $5.3M | 0.50% | 657,154 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $5.3M | 0.50% | 390,000 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $5.1M | 0.49% | 1,480,881 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $5.1M | 0.49% | 152,252 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $5.0M | 0.48% | 135,000 | CALL | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $4.9M | 0.47% | 1,700,000 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $4.7M | 0.45% | 2,224,196 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $4.7M | 0.45% | 3,045,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $4.6M | 0.44% | 3,341,519 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $4.4M | 0.42% | 200,000 | PUT | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $4.4M | 0.42% | 3,284,512 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $4.2M | 0.40% | 400,000 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $3.6M | 0.35% | 350,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.6M | 0.34% | 50,000 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $3.5M | 0.34% | 3,867,710 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $3.2M | 0.30% | 200,000 | PUT | SOLE |
| 45256X103 | IBRX | IMMUNITYBIO INC | $3.1M | 0.29% | 1,025,000 | PUT | SOLE |
| 00972D105 | AKBA | AKEBIA THERAPEUTICS INC | $2.9M | 0.27% | 1,500,000 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $2.8M | 0.26% | 250,000 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $2.7M | 0.26% | 241,957 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $2.7M | 0.26% | 100,000 | Common | SOLE |
| G6717R120 | OACCU | OAKTREE ACQUISITION CORP III | $2.6M | 0.25% | 250,000 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $2.5M | 0.24% | 1,330,700 | PUT | SOLE |
| 374163103 | GERN | GERON CORP | $2.4M | 0.23% | 1,500,000 | Common | SOLE |
| 61023L207 | MNPR | MONOPAR THERAPEUTICS INC | $2.3M | 0.22% | 62,000 | Common | SOLE |
| 363225202 | GALT | GALECTIN THERAPEUTICS INC | $2.2M | 0.21% | 1,836,200 | PUT | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $2.2M | 0.21% | 49,692 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $2.0M | 0.19% | 99,800 | CALL | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $2.0M | 0.19% | 800,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $2.0M | 0.19% | 263,817 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $1.8M | 0.17% | 1,500,000 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $1.7M | 0.16% | 394,159 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $1.5M | 0.15% | 75,000 | PUT | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $1.5M | 0.15% | 100,000 | CALL | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $1.5M | 0.14% | 150,000 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $1.5M | 0.14% | 800,000 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $1.4M | 0.14% | 390,000 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $1.3M | 0.12% | 175,000 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $1.3M | 0.12% | 370,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $1.3M | 0.12% | 175,000 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $1.3M | 0.12% | 200,000 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $1.2M | 0.12% | 325,000 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $1.1M | 0.11% | 2,302,598 | Common | SOLE |
| G59665102 | MGTX | MEIRAGTX HOLDINGS PLC | $1.0M | 0.10% | 150,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $944,000 | 0.09% | 25,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $603,750 | 0.06% | 25,000 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $489,721 | 0.05% | 752,722 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $404,280 | 0.04% | 660,589 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $387,500 | 0.04% | 250,000 | Common | SOLE |
| 75041J101 | RADX | RADIOPHARM THERANOSTICS LTD | $310,726 | 0.03% | 64,600 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $288,102 | 0.03% | 223,335 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $248,533 | 0.02% | 130,807 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $208,198 | 0.02% | 667,516 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $197,180 | 0.02% | 200,000 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $169,543 | 0.02% | 213,235 | Common | SOLE |
| 682143102 | OMER | OMEROS CORP | $81,855 | 0.01% | 9,958 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $56,900 | 0.01% | 250,000 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $45,832 | 0.00% | 27,777 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $3,525 | 0.00% | 75,000 | Common | SOLE |
| N44445117 | IMTXW | IMMATICS N.V | $2,958 | 0.00% | 187,204 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.